Table of Content
- INTRODUCTION
- Study Assumptions and Market Definition
- Scope of the Study
- RESEARCH METHODOLOGY
- EXECUTIVE SUMMARY
- MARKET DYNAMICS
- Market Overview
- Market Drivers
- Emergence of Multi Drug Resistance Due to Drug Abuse
- Market Restraints
- Limited Accessibility in Resource-Constrained Settings
- Challenges in Standardization and Interpretation of Results
- Market Opportunities
- Penetration into Untapped Markets
- Market Trends
- Rapid Adoption of Automated Systems
- Integration of Artificial Intelligence (AI) and Machine Learning (ML)
- MARKET SEGMENTATION
- By Product
- Manual Antimicrobial Susceptibility Testing Products
- Susceptibility Discs
- Susceptibility Plates
- Minimum Inhibitory Concentration (MIC) Strips
- Consumables
- Automated Antimicrobial Susceptibility Testing Products
- Manual Antimicrobial Susceptibility Testing Products
- By Method
- Disc Diffusion
- Automated AST
- Dilution
- Other Methods
- (Other methods include Etest, genotypic methods, and MALDI-TOF MS.)
- By Application
- Clinical Diagnostics
- Drug Discovery and Development
- Other Applications
- (Other applications include epidemiology, veterinary diagnostic, and environmental monitoring)
- By End User
- Diagnostic Laboratories and Hospitals
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutes
- By Product
- By Key Geographic Regions
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
- COMPETITIVE LANDSCAPE
- Company Profile
- Accelerate Diagnostics, Inc.
- AlifaxS.r.l.
- Bio-Rad Laboratories, Inc. (U.S.)
- bioMérieux S.A. (France)
- Becton
- Creative Diagnostics
- Dickinson and Company
- Danaher Corporation
- HiMedia Laboratories Pvt. Ltd.
- Merck KGaA (Germany)
- MERLIN Diagnostika GmbH
- Synbiosis
- Thermo Fisher Scientific Inc. (U.S.)
- Zhuhai DL Biotech Co., Ltd (China)
- Company Profile
- MARKET OPPORTUNITIES AND FUTURE TRENDS
Q.1. What is the projected market value of the global Antimicrobial Susceptibility Testingmarket?
The global market of antimicrobial susceptibility testing is projected to reach USD 6.4 Bn by 2033.
Q.2. What is the estimated growth rate (CAGR) of the global Antimicrobial Susceptibility Testingmarket?
The global antimicrobial susceptibility testing market has an estimated annual growth rate of 5.5% .
Q.3. What are the recent trends of Antimicrobial Susceptibility Testingmarket?
Rapid adoption of automated systems and integration of Artificial Intelligence (AI) and Machine Learning (ML)are some of the major trends of the market that is projected to boost the market growth in the near future.
Q.4. Which are the top companies to hold the market share in Antimicrobial Susceptibility Testing?
The major companies profiled in this report include Accelerate Diagnostics, Inc., AlifaxS.r.l., Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Creative Diagnostics, Dickinson and Company, Danaher Corporation, HiMedia Laboratories Pvt. Ltd., Merck KGaA (Germany), MERLIN Diagnostika GmbH, Synbiosis, Thermo Fisher Scientific Inc. (U.S.), Zhuhai DL Biotech Co., Ltd (China), among others.
Q.5. Which region is estimated to held highest CAGR inAntimicrobial Susceptibility Testingmarket?
North America is estimated to hold biggest share in the market for Antimicrobial Susceptibility Testing.